CD96 and neoplasm: To examine how CD96 deficiency in T cells and differential CD111 expression in these tumor cells modulated the cytotoxic capacity of T cells against tumor cells, we co-incubated CD96 WT or KO T cells with luciferase-expressing tumor cells at different E:T ratios for 20 h.